Quinpirole hydrochloride, a potential anti-parkinsonism drug
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 26 (8) , 1031-1036
- https://doi.org/10.1016/0028-3908(87)90245-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985
- Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned ratsPsychopharmacology, 1985
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- Elevation of Serum Corticosterone in Rats by Dopamine Agonists Related in Structure to PergolideNeuroendocrinology, 1983
- Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonistsJournal of Medicinal Chemistry, 1980
- Effect of central injections of dopamine on core temperature and thermoregulatory behaviour in unrestrained ratsNeuropharmacology, 1979
- Considerations in the management of parkinsonismNeurology, 1978
- Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidolBrain Research, 1977